Psychedelics and their use in mental health and neuroscience

LAB*: Truth | Talk

After a clampdown in the 1960s on the clinical research of compounds such as LSD, psilocybin (magic mushrooms) and MDMA – known colloquially as ‘psychedelics’ (derived from the Greek words ‘soul-revealing’) – there has been a modern renaissance in the scientific enquiry into their medical and therapeutic use. This revival is partly due to the enormous and growing burden of mental illnesses as well as lack of effective treatments in psychiatry.

This talk will give a summary of current research findings of psychedelics in the treatment of depression, anxiety, addiction, OCD, eating disorders and PTSD; as well as the neuroscience and psychology of how these compounds are thought to work. There will also be discussion on the principles of harm reduction and how individuals can benefit the academic and political efforts for better research and safer use. Cause knowledge in as many different fields as possible can give us the crucial assets to act wow by linking these learnings with each other!

Presenter: Dr David Charchoglyan, Centre for Psychedelic Research, Imperial College London